Impact of infectious diseases consultation on the management of Staphylococcus aureus bacteraemia in children

BMJ Open

Volumn 4, Issue 7, 2014, Pages

  Saunderson, Rebecca B ^a   Gouliouris, Theodore ^a,b,c   Cartwright, Edward J ^a,c   Nickerson, Emma J ^b   Aliyu, Sani H ^b   O'Donnell, D Roddy ^b   Kelsall, Wilf ^b   Limmathurotsakul, D ^d   Peacock, Sharon J ^a,b,c,e   Török, M Estée ^a,b,c  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b CAMBRIDGE UNIVERSITY HOSPITALS NHS FOUNDATION TRUST   (United Kingdom)

^c PUBLIC HEALTH ENGLAND   (United Kingdom)

^d MAHIDOL UNIVERSITY   (Thailand)

^e WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; DIMETHOATE;

ANTIBIOTIC THERAPY; ARTICLE; BLOOD CULTURE; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONSULTATION; FEMALE; HOSPITAL ADMISSION; HUMAN; INFECTIOUS DISEASE CONSULTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OSTEOMYELITIS; PNEUMONIA; RETROSPECTIVE STUDY; RISK FACTOR; SECONDARY INFECTION; STAPHYLOCOCCAL BACTEREMIA; TIME OF DEATH; TOTAL PARENTERAL NUTRITION; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; TREATMENT OUTCOME; VASCULAR ACCESS; ADOLESCENT; BACTEREMIA; DISEASE MANAGEMENT; FOLLOW UP; INFANT; ISOLATION AND PURIFICATION; MICROBIOLOGY; NEWBORN; PATIENT REFERRAL; PRESCHOOL CHILD; PROGNOSIS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

ADOLESCENT; ANTI-BACTERIAL AGENTS; BACTEREMIA; CHILD; CHILD, PRESCHOOL; DIMETHOATE; DISEASE MANAGEMENT; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT; INFANT, NEWBORN; MALE; PROGNOSIS; REFERRAL AND CONSULTATION; RETROSPECTIVE STUDIES; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 84903648831     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004659     Document Type: Article

References (42)

1. Burke RE, Halpern MS, Baron EJ, et al. Pediatric and neonatal Staphylococcus aureus bacteremia: epidemiology, risk factors, and outcome. Infect Control Hosp Epidemiol 2009;30:636-44.
2. Mylotte JM, Tayara A. Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 2000;31:1170-4. (Pubitemid 32295446)
3. Healy CM, Palazzi DL, Edwards MS, et al. Features of invasive staphylococcal disease in neonates. Pediatrics 2004;114:953-61. (Pubitemid 41529758)
4. Frederiksen MS, Espersen F, Frimodt-Møller N, et al. Changing epidemiology of pediatric Staphylococcus aureus bacteremia in Denmark from 1971 through 2000. Pediatr Infect Dis J 2007;26:398-405. (Pubitemid 46789320)
5. Hakim H, Mylotte JM, Faden H. Morbidity and mortality of Staphylococcal bacteremia in children. Am J Infect Control 2007;35:102-5.
6. Denniston S, Riordan FAI. Staphylococcus aureus bacteraemia in children and neonates: a 10 year retrospective review. J Infect 2006;53:387-93. (Pubitemid 44688978)
7. Hill PC, Wong CGS, Voss LM, et al. Prospective study of 125 cases of Staphylococcus aureus bacteraemia in children in New Zealand. Pediatr Infect Dis J 2001;20:868-73. (Pubitemid 32880322)
8. Gray J, O'Donoghue B. Bacteraemia with meticillin-susceptible Staphylococcus aureus in an English children's hospital. J Hosp Infect 2011;78:158-9.
9. Groome MJ, Albrich WC, Wadula J, et al. Community-onset Staphylococcus aureus bacteraemia in hospitalised African children: high incidence in HIV-infected children and high prevalence of multidrug resistance. Paediatr Int Child Health 2012;32:140-6.
10. Suryati BA, Watson M. Staphylococcus aureus bacteraemia in children: a 5-year retrospective review. J Paediatr Child Health 2002;38:290-4. (Pubitemid 34592187)
11. Wyllie DH, Crook DW, Peto TEA. Mortality after Staphylococcus aureus bacteraemia in two hospitals in Oxfordshire, 1997-2003: cohort study. BMJ 2006;333:281.
12. Friendland IR, du Plessis J, Cilliers A. Cardiac complications in children with Staphylococcus aureus bacteremia. J Pediatr 1995;127:476-8.
13. Carrillo-Marquez MA, Hulten KG, Mason EO, et al. Clinical and molecular epidemiology of Staphylococcus aureus catheter-related bacteremia in children. Pediatr Infect Dis J 2010;29:410-14.
14. Fowler VG, Sanders LL, Sexton DJ, et al. Outcome of Staphylococcus aureus bacteremia according to compliance with recommendations of infectious diseases specialists: experience with 244 patients. Clin Infect Dis 1998;27:478-86. (Pubitemid 28421994)
15. Lillie P, Moss P, Thaker H, et al. Development, impact and outcomes of the Hull Bacteraemia Service. QJM 2008;101:889-98.
16. Nagao M, Iinuma Y, Saito T, et al. Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia. Clin Microbiol Infect 2010;16:1783-8.
17. Robinson JO, Pozzi-Langhi S, Phillips M, et al. Formal infectious diseases consultation is associated with decreased mortality in Staphylococcus aureus bacteraemia. Eur J Clin Microbiol Infect Dis 2012;31:2421-8.
18. Jenkins TC, Price CS, Sabel AL, et al. Impact of routine infectious diseases service consultation on the evaluation, management, and outcomes of Staphylococcus aureus bacteremia. Clin Infect Dis 2008;46:1000-8. (Pubitemid 351589864)
19. Choi S-H, Cho SY, Park J-H, et al. Impact of infectious-disease specialist consultations on outcomes of Staphylococcus aureus bacteremia in a hospital with a low volume of patients with S. aureus bacteremia. J Infect 2011;62:181-5.
20. Kaech C, Elzi L, Sendi P, et al. Course and outcome of Staphylococcus aureus bacteraemia: a retrospective analysis of 308 episodes in a Swiss tertiary-care centre. Clin Microbiol Infect 2006;12:345-52. (Pubitemid 43337524)
21. Honda H, Krauss MJ, Jones JC, et al. The value of infectious diseases consultation in Staphylococcus aureus bacteremia. Am J Med 2010;123:631-7.
22. Rieg S, Peyerl-Hoffmann G, de With K, et al. Mortality of S. aureus bacteremia and infectious diseases specialist consultation - a study of 521 patients in Germany. J Infect 2009;59:232-9.
23. De La Blanchardière A, Boutemy J, Thibon P, et al. Clinical benefit of infectious diseases consultation: a monocentric prospective cohort study. Infection 2012;40:501-7.
24. Forsblom E, Ruotsalainen E, Ollgren J, et al. Telephone consultation cannot replace bedside infectious disease consultation in the management of Staphylococcus aureus bacteremia. Clin Infect Dis 2013;56:527-35.
25. Tissot F, Calandra T, Prod'hom G, et al. Impact of infectious diseases consultation on outcome of methicillin-resistant Staphylococcus aureus bacteraemia in a tertiar centre: a ten-year experience. Clin Microbiol Infect 2011;17:S420-1.
26. Minton J, Clayton J, Sandoe J, et al. Improving early management of bloodstream infection: a quality improvement project. BMJ 2008;336:440-3. (Pubitemid 351310891)
27. Lundberg J, Nettleman MD, Costigan M, et al. Staphylococcus aureus bacteraemia: the cost effectiveness of long-term therapy associated with infectious diseases consultation. Clin Perform Qual Health Care 1998;6:9-11.
28. Enoch DA, Cooke FJ, Guha S, et al. Thermostable nuclease: a study of clinical impact. J Antimicrob Chemother 2008;61:754-5. (Pubitemid 351321161)
29. BSAC. BSAC Methods for Antimicrobial Susceptibility Testing, Version 12 May 2013. http://bsac.org.uk/wp-content/uploads/2012/02/Version-12-Apr-2013- final.pdf
30. Libman H, Arbeit R. Complications associated with Staphylococcus aureus bacteraemia. Arch Intern Med 1984;144:541-5. (Pubitemid 14152738)
31. Horan TC, Andrus M, Dudeck MA. CDC/NHSN surveillance definition of healthcare-associated infection and criteria for specific types of infections in the acute care setting. 2008;36:309-32.
32. Li JS, Sexton DJ, Mick N, et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2000;30:633-8.
33. Durack DT, Lukes AS, Bright DK. New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Am J Med 1994;96:200-9.
34. Friedman ND, Kaye KS, Stout JE, et al. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann Intern Med 2002;10:791-7. (Pubitemid 35334450)
35. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin- resistant Staphylococcus aureus infections in adults and children. Clin Infect Dis 2011;52:e18-55.
36. Fowler VG, Olsen MK, Corey GR, et al. Clinical identifiers of complicated Staphylococcus aureus bacteraemia. Arch Inter Med 2003;163:2066-72. (Pubitemid 37151249)
37. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 Update by the Infectious Diseases Society of America. Clin Infect Dis 2009;49:1-45.
38. Thwaites GE, Edgeworth JD, Gkrania-Klotsas E, et al. Clinical management of Staphylococcus aureus bacteraemia. Lancet Infect Dis 2011;11:208-22.
39. Calain P, Krause KH, Vaudaux P, et al. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections. J Infect Dis 1987;155:187-91. (Pubitemid 17022856)
40. Valente AM, Jain R, Scheurer M, et al. Frequency of infective endocarditis among infants and children with Staphylococcus aureus bacteremia. Pediatrics 2005;115:e15-19. (Pubitemid 43046258)
41. Ross AC, Toltzis P, O'Riordan MA, et al. Frequency and risk factors for deep focus of infection in children with Staphylococcus aureus bacteremia. Pediatr Infect Dis J 2008;27:396-9.
42. Johnson AP, Sharland M, Goodall CM, et al. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland. Arch Dis Child 2010;95:781-5.